文献速递浆细胞疾病

隧道纳米管介导的细丝蛋白A跨细胞运输机械敏化编程骨髓瘤骨病中的破骨细胞生成

Tunneling nanotube-mediated intercellular filamin A transport mechanosensitively programs osteoclastogenesis in myeloma bone disease.
PubMed 文献 · Blood · 2026-01-01

该研究发现多发性骨髓瘤(MM)细胞与破骨前体细胞(pre-OCs)通过隧道纳米管(TNTs)直接连接,并鉴定出细丝蛋白A(FLNA)是从MM细胞转运至pre-OCs的主要蛋白。FLNA通过激活Rho和MAPK通路、促进F-actin聚合及增强足小体功能,机械敏化地促进破骨细胞分化和骨吸收。在Vk*MYC骨髓瘤小鼠模型中,TNT抑制剂latrunculin B可破坏FLNA转运并缓解溶骨性骨病。

要点

  • MM细胞通过TNTs向pre-OCs转运FLNA,促进破骨细胞生成。
  • FLNA通过调控细胞刚度、牵引力和变形能力增强破骨细胞功能。
  • 靶向TNTs可能成为限制MM相关病理性骨吸收的治疗策略。

核心结论

  • MM细胞通过TNTs向pre-OCs转运FLNA,机械敏化地编程破骨细胞生成,促进骨髓瘤骨病。

研究设计与样本

  • 基础研究结合小鼠模型:体外共培养、稳定同位素标记氨基酸培养(SILAC) assay、正负双选策略鉴定转运蛋白,Flna条件性敲除小鼠及Vk*MYC骨髓瘤小鼠模型。

主要发现

  • TNTs直接连接MM与pre-OCs,FLNA是从MM转运至pre-OCs的主要蛋白。
  • FLNA作为分子离合器连接MAC1与细胞骨架,激活Rho和MAPK通路,促进F-actin聚合。
  • FLNA直接结合vinculin并促进其募集至足小体,增强足小体功能和骨吸收能力。
  • Flna条件性敲除小鼠pre-OCs足小体活性降低,刚度、牵引力和变形能力下降,破骨细胞分化受损,骨量增加。
  • Vk*MYC骨髓瘤小鼠中给予TNT抑制剂latrunculin B可破坏FLNA向破骨细胞转运并缓解溶骨性骨病。

临床怎么用

  • 靶向TNTs或FLNA转运可能成为限制MM相关病理性骨吸收的潜在治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Intercellular communication between multiple myeloma (MM) cells and osteoclast precursor cells (pre-OCs) contributes extensively to the occurrence and development of myeloma-related bone destruction. However, key interacting modes and the exchanged substances involved in this communication remain unclear. In this study, we discover that tunneling nanotubes (TNTs) directly connect MM and pre-OCs. Using the stable isotope labeling with amino acids in cell culture assay and a positive-negative double selection strategy, we identify filamin A (FLNA) as a major protein transported from MM to pre-OCs. FLNA acts as a molecular clutch linking extracellular matrix-bound MAC1 to the cytoskeleton, activating Rho and MAPK signaling pathways and promoting F-actin polymerization, which subsequently enhances osteoclast differentiation by modulating cellular stiffness, traction force, and deformability. In addition, FLNA directly binds vinculin and promotes its recruitment to podosomes, thereby enhancing the functions of podosomes and the bone resorption capacity of osteoclasts. The conditional depletion of Flna in mice suppresses podosome activity and reduces stiffness, traction force, and deformability in pre-OCs, leading to significantly impaired osteoclast differentiation and increased bone mass. In the Vk∗MYC mouse model of myeloma, the administration of the TNT inhibitor latrunculin B disrupts FLNA transport to osteoclasts and alleviates osteolytic bone disease. These findings highlight the critical role of MM-transferred FLNA in osteoclastogenesis and suggest that targeting TNTs may represent a therapeutic strategy to limit pathological bone resorption associated with MM.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Guo J, Wang J, Xie Y, et al. Tunneling nanotube-mediated intercellular filamin A transport mechanosensitively programs osteoclastogenesis in myeloma bone disease. Blood. 2026. PMID: 41950002. doi:10.1182/blood.2025031627

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。